tetano
Editor, Senior Moderator
Virol Sin
. 2024 Sep 2:S1995-820X(24)00139-1.
doi: 10.1016/j.virs.2024.08.012. Online ahead of print. Antigenic analysis of the influenza B virus hemagglutinin protein
Mengyi Zhang[SUP] 1 [/SUP], Chaoying Yang[SUP] 2 [/SUP], Xi Wu[SUP] 3 [/SUP], Yifei Wang[SUP] 3 [/SUP], Lijie Wang[SUP] 3 [/SUP], Qianqian Cui[SUP] 3 [/SUP], Jincheng Tong[SUP] 3 [/SUP], Yimeng An[SUP] 3 [/SUP], Meina Cai[SUP] 3 [/SUP], Shishi Cheng[SUP] 3 [/SUP], Qi Jiang[SUP] 3 [/SUP], Yulin Wang[SUP] 4 [/SUP], Chenyan Zhao[SUP] 5 [/SUP], Youchun Wang[SUP] 6 [/SUP], Weijin Huang[SUP] 7 [/SUP]
Affiliations
Influenza B viruses (IBVs) primarily infect humans and are a common cause of respiratory infections in humans. Here, to systematically analyze the antigenicity of the IBVs Hemagglutinin (HA) protein, 31 B/Victoria and 19 B/Yamagata representative circulating strains were selected from Global Initiative of Sharing All Influenza Data (GISAID), and pseudotyped viruses were constructed with the vesicular stomatitis virus system. Guinea pigs were immunized with three doses of vaccines (one dose of DNA vaccines following two doses of pseudotyped virus vaccines) of the seven IBV vaccine strains, and neutralizing antibodies against the pseudotyped viruses were tested. By comparing differences between various vaccine strains, we constructed several pseudotyped viruses that contained various mutations based on vaccine strain BV-21. The vaccine strains showed good neutralization levels against the epidemic virus strains of the same year, with neutralization titers ranging from 370 to 840, while the level of neutralization against viruses prevalent in previous years decreased 1-10-fold. Each of the high-frequency epidemic strains of B/Victoria and B/Yamagata not only induced high neutralizing titers, but also had broadly neutralizing effects against virus strains of different years, with neutralizing titers ranging from 1000 to 7200. R141G, D197N, and R203K were identified as affecting the antigenicity of IBV. In this study, pseudotyped virus system was used to monitor the cross-neutralizing efficacy of high-frequency epidemic strains and vaccine strains recommended by the World Health Organization. Additionally, we identified three mutation sites that can seriously affect the antigenicity of B/Victoria vaccine strains. These mutation sites provide valuable references for the selection and design of a universal IBV vaccine strain in the future.
Keywords: Antigenicity; Influenza B virus (IBV); Pseudotyped viruses; Vaccine strains.
. 2024 Sep 2:S1995-820X(24)00139-1.
doi: 10.1016/j.virs.2024.08.012. Online ahead of print. Antigenic analysis of the influenza B virus hemagglutinin protein
Mengyi Zhang[SUP] 1 [/SUP], Chaoying Yang[SUP] 2 [/SUP], Xi Wu[SUP] 3 [/SUP], Yifei Wang[SUP] 3 [/SUP], Lijie Wang[SUP] 3 [/SUP], Qianqian Cui[SUP] 3 [/SUP], Jincheng Tong[SUP] 3 [/SUP], Yimeng An[SUP] 3 [/SUP], Meina Cai[SUP] 3 [/SUP], Shishi Cheng[SUP] 3 [/SUP], Qi Jiang[SUP] 3 [/SUP], Yulin Wang[SUP] 4 [/SUP], Chenyan Zhao[SUP] 5 [/SUP], Youchun Wang[SUP] 6 [/SUP], Weijin Huang[SUP] 7 [/SUP]
Affiliations
- PMID: 39233140
- DOI: 10.1016/j.virs.2024.08.012
Influenza B viruses (IBVs) primarily infect humans and are a common cause of respiratory infections in humans. Here, to systematically analyze the antigenicity of the IBVs Hemagglutinin (HA) protein, 31 B/Victoria and 19 B/Yamagata representative circulating strains were selected from Global Initiative of Sharing All Influenza Data (GISAID), and pseudotyped viruses were constructed with the vesicular stomatitis virus system. Guinea pigs were immunized with three doses of vaccines (one dose of DNA vaccines following two doses of pseudotyped virus vaccines) of the seven IBV vaccine strains, and neutralizing antibodies against the pseudotyped viruses were tested. By comparing differences between various vaccine strains, we constructed several pseudotyped viruses that contained various mutations based on vaccine strain BV-21. The vaccine strains showed good neutralization levels against the epidemic virus strains of the same year, with neutralization titers ranging from 370 to 840, while the level of neutralization against viruses prevalent in previous years decreased 1-10-fold. Each of the high-frequency epidemic strains of B/Victoria and B/Yamagata not only induced high neutralizing titers, but also had broadly neutralizing effects against virus strains of different years, with neutralizing titers ranging from 1000 to 7200. R141G, D197N, and R203K were identified as affecting the antigenicity of IBV. In this study, pseudotyped virus system was used to monitor the cross-neutralizing efficacy of high-frequency epidemic strains and vaccine strains recommended by the World Health Organization. Additionally, we identified three mutation sites that can seriously affect the antigenicity of B/Victoria vaccine strains. These mutation sites provide valuable references for the selection and design of a universal IBV vaccine strain in the future.
Keywords: Antigenicity; Influenza B virus (IBV); Pseudotyped viruses; Vaccine strains.